P. YR, B. . M, and S. . CK, “GLYCEMIC CONTROL AND BODY WEIGHT EFFECTS OF 25 MG FULL TABLET VERSUS 12.5 MG HALF TABLET EMPAGLIFLOZIN IN THE TREATMENT OF TYPE 2 DIABETES (T2D): A SINGLE CENTRE EXPERIENCE”, J ASEAN Fed Endocr Soc, vol. 36, p. 44, Jul. 2021.